Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes
Peters plus syndrome (PPS) is a rare autosomal‐recessive disorder characterized by Peters anomaly of the eye, short stature, brachydactyly, dysmorphic facial features, developmental delay, and variable other systemic abnormalities. In this report, we describe screening of 64 patients affected with P...
Saved in:
Published in: | Clinical genetics Vol. 86; no. 2; pp. 142 - 148 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford, UK
Blackwell Publishing Ltd
01-08-2014
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Peters plus syndrome (PPS) is a rare autosomal‐recessive disorder characterized by Peters anomaly of the eye, short stature, brachydactyly, dysmorphic facial features, developmental delay, and variable other systemic abnormalities. In this report, we describe screening of 64 patients affected with PPS, isolated Peters anomaly and PPS‐like phenotypes. Mutations in the coding region of B3GALTL were identified in nine patients; six had a documented phenotype of classic PPS and the remaining three had a clinical diagnosis of PPS with incomplete clinical documentation. A total of nine different pathogenic alleles were identified. Five alleles are novel including one frameshift, c.168dupA, p.(Gly57Argfs*11), one nonsense, c.1234C>T, p.(Arg412*), two missense, c.1045G>A, p.(Asp349Asn) and c.1181G>A, p.(Gly394Glu), and one splicing, c.347+5G>T, mutations. Consistent with previous reports, the c.660+1G>A mutation was the most common mutation identified, seen in eight of the nine patients and accounting for 55% of pathogenic alleles in this study and 69% of all reported pathogenic alleles; while two patients were homozygous for this mutation, the majority had a second rare pathogenic allele. We also report the absence of B3GALTL mutations in 55 cases of PPS‐like phenotypes or isolated Peters anomaly, further establishing the strong association of B3GALTL mutations with classic PPS only. |
---|---|
Bibliography: | ArticleID:CGE12241 National Institutes of Health - No. R01EY015518; No. R21DC010912 Children's Hospital of Wisconsin (EVS) ark:/67375/WNG-QFFSSBRP-L Table S1. Phenotype summary of B3GALTL-negative PPS-like cases reported in this study and literatureTable S2. Summary of rare likely benign variants identified in B3GALTLFigure S1. (a) Novel B3GALTL mutations in Peters plus syndrome patients identified in this study. The position of each mutation is indicated with a black arrow. (b) Results of TaqMan copy number assays targeting 5′ (intron 1) and 3′ (exon 14) regions of B3GALTL that were performed on DNA samples from Patients 1, 3 and 8, who appeared homozygous for the common c.660+1G>A splicing mutation, alongside a control sample with diploid B3GALTL copy number; haploid copy number for both probes was detected for Patient 1 (arrow) while Patients 3 and 8 were diploid for both probes. (c) Evolutionary conservation of amino acid residues affected by missense mutations identified in Patients 7 and 9; note 100% conservation of both positions in vertebrates (box). Clinical and Translational Science Award (CTSA) program - No. 1UL1RR031973 istex:EE28BC017398721D30A913124B950535E464E2B7 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 These authors contributed equally to this work |
ISSN: | 0009-9163 1399-0004 |
DOI: | 10.1111/cge.12241 |